Archive

PEPFAR expands ARV purchases from local African suppliers

The US government is throwing its weight behind African production of antiretroviral drugs as the continent grapples with the world’s largest HIV epidemic.

Health Department seeks affordable CAB-LA for HIV prevention

South Africa’s Health Department seeks affordable CAB-LA prices following a US donation, aiming to ensure sustainable access to this long-acting HIV prevention injection and reduce new infections across the country.

CMS seeks to overturn court ruling on Medipos Medical Scheme

The medical schemes regulator is appealing a court decision to remove curatorship from Medipos, citing financial instability and governance issues.

Lenacapavir offers key HIV treatment advances

A new HIV prevention drug, lenacapavir, has shown 100% protection in trials, offering hope for young women in Africa. Professor Linda-Gail Bekker believes it could be a game-changer in HIV prevention.

HIV prevalence: health challenges and progress

Women in SA face higher HIV rates due to early sexual activity, low condom use, and multiple partners. Activists urge targeted interventions and support.

High Court ruling on certificate of need not linked to NHI

The Pretoria High Court overturned the certificate of need requirement for healthcare facilities. Health Minister Aaron Motsoaledi clarified that this ruling is unrelated to the National Health Insurance scheme.

Doctors celebrate ruling on ‘unconstitutional legislation’

Doctors celebrate the Pretoria High Court ruling declaring legislation allowing government control over practice locations unconstitutional. This is a significant setback for the National Health Insurance (NHI), which is reliant on central management.

High Court rejects controversial Certificate of Need

The High Court in Pretoria has ruled against the health minister’s plan to control doctor placements. The court declared the National Health Act’s certificate of need provisions unconstitutional, impacting the National Health Insurance scheme.

Pharma companies aim to halve CAR-T therapy production time

Big pharma giants are cutting CAR-T therapy manufacturing time to expand access for aggressive cancer patients, aiming for faster, life-extending treatments.

Addressing the economic impact of sick days in South Africa

Sick days cost the economy an estimated R19 billion annually. Do South African employees need more support to stay healthy and productive at work?

SA’s groundbreaking HIV research on elite controllers

South Africa’s research on elite controllers uncovers unique genetic factors in HIV control, promising new treatments and vaccines for African populations.

US pharmaceutical industry intermediaries defend their role

Pharmacy benefit managers defended their roles in a Congressional hearing amid accusations of promoting expensive treatments. Executives claimed their models save money, while a report highlighted anti-competitive practices and high drug prices.